The New Science of Menopause: Brain, Hormones, and Metabolism
Dr. Mary Claire Haver joins Dr. Vonda Wright to unpack what the newest science reveals about perimenopause and menopause. They trace the research gap, the brain remodeling behind early symptoms, and how nuanced hormone, bone, and metabolic care can reshape the next thirty years of a woman's life.
Overview
This wide-ranging conversation opens with a striking fact: there is almost no large-scale research on perimenopause, with roughly 9,000 articles compared to 1.2 million for pregnancy. Dr. Haver explains that perimenopause has no agreed definition and can begin in the mid-30s, often showing up first as brain fog, sleep disruption, and mood changes driven by a neuroendocrine remodeling of the brain.
The two physicians discuss why this transition was long dismissed and how simply naming it brings relief. They explore hormone therapy for mental health, the outdated guidelines gap between ACOG and the Menopause Society, and the shift toward measuring hormone levels and absorption. A major thread is bone: low estradiol guarantees bone loss, and the protective effect is dose-related, with about 20 percent of women absorbing transdermal estrogen poorly.
The talk turns to GLP-1 medications, which Dr. Haver prescribes only alongside body composition tracking to protect muscle and bone. They define the metabolic syndrome of menopause, including the surge in visceral fat and a rise in LDL of up to 28 percent. The episode closes with progesterone intolerance, testosterone in women, and a shared hope that one day menopause care will be as normal and well-supported as puberty.
Key quotes
5There's not a single large-scale randomized controlled study for the treatment of perimenopause. Zero.
I'm not the same person even though I'm living the same life. I'm eating the same things. I have no new stress. And just my resilience is different.
All women who go through menopause who have low estradiol levels will lose bone. This is non-negotiable.
We see an expansion from 7 to 10 percent of our visceral fat, which is a healthy level, and it goes up well above 20 percent, just from going through menopause.
The time to approach it is now. Not yesterday. Now. Today.
Key ideas
8A research desert
Perimenopause has roughly 9,000 studies versus 1.2 million for pregnancy and 3.2 million for a single knee ligament. With no large-scale randomized trial, care relies on clinical experience and expert opinion.
The brain goes first
Perimenopause is a neuroendocrine transition that structurally remodels the brain before periods stop. This drives brain fog, sleep disruption, and mood changes even when life circumstances are unchanged.
Hormones and mental health
New-onset anxiety, depression, rage, or racing thoughts without a life trigger may respond to hormone therapy. A steady transdermal estradiol patch can calm the brain more effectively than before.
The guidelines gap
Menopause Society guidance was updated in 2022 while ACOG's dates to 2014, and most OB/GYNs are not members of the Menopause Society. This leaves many women receiving outdated care.
Bone loss is dose-related
Low estradiol guarantees bone loss, but higher blood levels progressively slow it, stabilize it, and can even build bone. Treating only to stop hot flashes may leave women short of full bone protection.
Care is an N of one
There is no cookie-cutter protocol. Choices between oral and transdermal estrogen, dosing, and added testosterone depend on each woman's goals and risks, from clotting to cholesterol.
The metabolic syndrome of menopause
Menopause directly worsens blood pressure, abdominal fat, triglycerides, and LDL, which can rise up to 28 percent. Women are often blindsided and wrongly blamed for a hormone-driven shift.
Progesterone intolerance is real
About 10 to 15 percent of women react paradoxically to progesterone with grogginess or anxiety. Alternatives include oral micronized progesterone, a progesterone IUD, or the estrogen-blocking option Duavee.
Practical takeaways
7- 1
Treat new mood symptoms as a clue 17:30
If anxiety, depression, or rage appears without any life trigger, consider that it may be hormonal and worth discussing hormone therapy with a knowledgeable clinician.
- 2
Flag your hypoestrogenic history 20:30
A rough postpartum period or struggles while nursing can signal higher risk later, so mention them so your care team can watch early and treat quickly.
- 3
Ask about levels and absorption 24:00
Since about one in five women absorb transdermal estrogen poorly, ask whether checking blood levels makes sense for your goals rather than dosing only to the hot flash.
- 4
Pair GLP-1s with body composition 34:00
If using a GLP-1, track protein, fiber, muscle mass, and visceral fat so weight loss protects rather than erodes your long-term bone and muscle infrastructure.
- 5
Know the metabolic criteria 42:00
Waist size, blood pressure, triglycerides, HDL, and LDL can all shift at menopause; knowing the pattern helps you and your clinician connect the dots instead of self-blame.
- 6
Progesterone has alternatives 46:00
If a progesterone makes you groggy or anxious, know that other forms and delivery routes exist, so one bad reaction does not mean hormone therapy is off the table.
- 7
Start building strength now 47:30
Strength training and protein are motivators for the brain and bones, not the mirror; framing exercise around future independence is a more durable driver than appearance.
Topics & chapters
15The menopause transition begins
A cold open on visceral fat and metabolic chaos sets up a conversation with menopause expert Dr. Mary Claire Haver.
A research desert
Only around 9,000 perimenopause studies exist, far fewer than for pregnancy or a single knee ligament.
No clear definition
Perimenopause has no agreed definition and can begin in the mid-30s when women stop feeling like themselves.
The brain in transition
New research shows profound hormonal variability remodeling the brain, driving the earliest symptoms.
Normalizing the conversation
From Victorian hysteria to the modern water cooler, naming the transition itself brings relief and reduces shame.
Mental health and hormone therapy
Hormone therapy, especially a transdermal estradiol patch, can help new-onset mood symptoms with no life trigger.
Hypoestrogenic warning signs
Postpartum and nursing struggles may predict later risk, signaling who to watch early and treat fast.
Testing and the guidelines gap
Outdated ACOG guidance versus the 2022 Menopause Society update, and why testing hormone levels is debated.
Bone loss, dosing, and absorption
Estradiol protects bone in a dose-related way, yet about 20 percent of women absorb transdermal estrogen poorly.
Nuanced, N-of-one care
Why menopause care is precision medicine, not a recipe, balancing goals, risks, and the absence of trials.
GLP-1s and body composition
A careful protocol tracks muscle and bone so weight loss does not rob long-term infrastructure.
Visceral versus subcutaneous fat
Visceral fat surges in menopause and is tied to diabetes, stroke, and cardiovascular disease.
The metabolic syndrome of menopause
Blood pressure, abdominal fat, triglycerides, and LDL all shift, and HRT may attenuate the change.
Progesterone intolerance and options
Paradoxical reactions affect many women, with alternatives from IUDs to Duavee for high-risk patients.
Testosterone and the future
Testosterone's role in desire, bone, and cognition, and a shared hope that menopause care becomes as normal as puberty.